Baylor College of Medicine1d
Transforming the recognition and management of persistent chylomicronemia
A new framework for the categorization and management of chylomicronemia - an extreme form of hypertriglyceridemia defined as triglyceride (TG) ...
Morningstar12d
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
therapeutic for severe hypertriglyceridemia (SHTG), mixed dyslipidemia, and familial chylomicronemia syndrome (FCS) treatment. The company plans to advance RN0361 development in HTG patients based ...
Nature3y
1115 Hemophagocytic Lymphohistiocytosis in Two Romanian Young Infants
HLH is characterized by fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia and ... one of them - a rare case of primary HLH form (familial form), and other - the secondary form of HLH ...
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 ...